MORGAN STANLEY PLC/CALL/STRYKER CORP./425/0.1/19.12.25 Share Price

Warrant

DE000MG0YGY4

Real-time Bid/Ask 09:12:09 07/06/2024 pm IST
2.15 EUR / 2.19 EUR +6.90% Intraday chart for MORGAN STANLEY PLC/CALL/STRYKER CORP./425/0.1/19.12.25
Current month+11.54%
1 month+26.88%
Date Price Change
07/24/07 2.13 +4.93%
06/24/06 2.03 +2.01%
05/24/05 1.99 +3.65%
04/24/04 1.92 +6.67%
03/24/03 1.8 -1.10%

Delayed Quote Börse Stuttgart

Last update June 07, 2024 at 07:49 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer Morgan Stanley
WKN MG0YGY
ISINDE000MG0YGY4
Date issued 27/03/2024
Strike 425 $
Maturity 19/12/2025 (560 Days)
Parity 10 : 1
Emission price 2.6
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.01
Lowest since issue 1.46
Spread 0.04
Spread %1.81%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
349.6 USD
Average target price
373.1 USD
Spread / Average Target
+6.70%
Consensus